These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7009055)

  • 1. Low dose injectable contraceptive norethisterone enanthate 20mg monthly--I. Clinical trials.
    Prema K; Gayathri TL; Ramalakshmi BA; Madhavapeddi R; Philips FS
    Contraception; 1981 Jan; 23(1):11-22. PubMed ID: 7009055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further study on the effect of norethisterone enanthate, an injectable contraceptive on body functions.
    Ali MN; Jalil MA
    Bangladesh Med Res Counc Bull; 1978 Dec; 4(2):63-70. PubMed ID: 575036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose injectable contraceptive norethisterone enanthate 20mg monthly - II. Metabolic side effects.
    Bamji MS; Safaya S; Prema K
    Contraception; 1981 Jan; 23(1):23-36. PubMed ID: 7471743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two years' clinical experience with norethisterone enanthate as a prolonged-action injectable contraceptive].
    Larranaga A; Kesseru E
    Ginecol Obstet (Lima); 1968 Aug; 14(2):209-21. PubMed ID: 12305607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statement on injectable contraception.
    International Planned Parenthood Federation IPPF
    IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return of ovulation and fertility in women using norethisterone oenanthate.
    Fotherby K; Yong-En S; Howard G; Elder MG; Muggeridge J
    Contraception; 1984 May; 29(5):447-55. PubMed ID: 6744861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Meng YX; Virutamasen P
    Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with a prolonged-action injectable hormonal contraceptive].
    Larranaga Legula A; Kesseru E
    Ginecol Obstet (Lima); 1967; 13(1-2):49-58. PubMed ID: 12305606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICMR (Indian Council of Medical Research) Task Force on Hormonal Contraception. Return of fertility following discontinuation of an injectable contraceptive--norethisterone oenanthate (NET EN) 200mg dose. Council of Medical Research.
    Contraception; 1986 Dec; 34(6):573-82. PubMed ID: 3549141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
    Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.